Literature DB >> 23008411

Reperfusion brain injury: focus on cellular bioenergetics.

Svetlana Pundik1, Kui Xu, Sophia Sundararajan.   

Abstract

Energy production for the maintenance of brain function fails rapidly with the onset of ischemia and is reinstituted with timely reperfusion. The key bioenergetic organelle, the mitochondrion, is strongly affected by a cascade of events occurring with ischemia and reperfusion. Enhanced production of reactive oxygen species, disruption of calcium homeostasis, and an inflammatory response are induced by reperfusion and have a profound effect on cellular bioenergetics in reversible stroke. The impact of perturbed bioenergetics on cellular homeostasis/function during and after ischemia are discussed. Because mitochondrial function can be compromised by derangements at more than one of the susceptible sites on this organelle, we propose that a combination therapy is needed for the restoration and maintenance of cellular bioenergetics after reperfusion.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23008411     DOI: 10.1212/WNL.0b013e3182695a14

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  33 in total

1.  Neuronal expression of the mitochondrial protein prohibitin confers profound neuroprotection in a mouse model of focal cerebral ischemia.

Authors:  Anja Kahl; Corey J Anderson; Liping Qian; Henning Voss; Giovanni Manfredi; Costantino Iadecola; Ping Zhou
Journal:  J Cereb Blood Flow Metab       Date:  2017-07-17       Impact factor: 6.200

2.  Simvastatin pretreatment protects cerebrum from neuronal injury by decreasing the expressions of phosphor-CaMK II and AQP4 in ischemic stroke rats.

Authors:  Min-xia Zhu; Chao Lu; Chun-mei Xia; Zhong-wei Qiao; Da-nian Zhu
Journal:  J Mol Neurosci       Date:  2014-04-23       Impact factor: 3.444

Review 3.  Blood-brain barrier dysfunction in ischemic stroke: targeting tight junctions and transporters for vascular protection.

Authors:  Wazir Abdullahi; Dinesh Tripathi; Patrick T Ronaldson
Journal:  Am J Physiol Cell Physiol       Date:  2018-06-27       Impact factor: 4.249

4.  Berberine attenuates ischemia-reperfusion injury through inhibiting HMGB1 release and NF-κB nuclear translocation.

Authors:  Jun-Rong Zhu; Hai-Dan Lu; Chao Guo; Wei-Rong Fang; Hong-Dong Zhao; Jun-Shan Zhou; Feng Wang; Yan-Li Zhao; Yun-Man Li; Ying-Dong Zhang; Chang-Qing Yang; Jian-Guo Sun
Journal:  Acta Pharmacol Sin       Date:  2018-11       Impact factor: 6.150

5.  TRPM4 activation by chemically- and oxygen deprivation-induced ischemia and reperfusion triggers neuronal death.

Authors:  Elías Leiva-Salcedo; Denise Riquelme; Oscar Cerda; Andrés Stutzin
Journal:  Channels (Austin)       Date:  2017-10-05       Impact factor: 2.581

6.  Post-conditioning and reperfusion injury in the treatment of stroke.

Authors:  Roger Simon
Journal:  Dose Response       Date:  2014-07-07       Impact factor: 2.658

7.  cGMP-selective phosphodiesterase inhibitors stimulate mitochondrial biogenesis and promote recovery from acute kidney injury.

Authors:  Ryan M Whitaker; Lauren P Wills; L Jay Stallons; Rick G Schnellmann
Journal:  J Pharmacol Exp Ther       Date:  2013-09-16       Impact factor: 4.030

8.  The neuro-critical care management of the endovascular stroke patient.

Authors:  Vishal N Patel; Rishi Gupta; Christopher M Horn; Tommy T Thomas; Raul G Nogueira
Journal:  Curr Treat Options Neurol       Date:  2013-04       Impact factor: 3.598

9.  Early bispectral index and sedation requirements during therapeutic hypothermia predict neurologic recovery following cardiac arrest.

Authors:  Nicholas E Burjek; Chad E Wagner; Ryan D Hollenbeck; Li Wang; Chang Yu; John A McPherson; Frederic T Billings
Journal:  Crit Care Med       Date:  2014-05       Impact factor: 7.598

10.  Targeting CD36-mediated inflammation reduces acute brain injury in transient, but not permanent, ischemic stroke.

Authors:  Eun-Hee Kim; Aaron T Tolhurst; Hazel H Szeto; Sung-Hee Cho
Journal:  CNS Neurosci Ther       Date:  2014-09-12       Impact factor: 5.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.